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I.  INTRODUCTION 
 
In 1831 Jacob Bigelow, a Harward professor, used the 
word in the title of his book Elements of Technology 
on Application of the Sciences to the Useful Arts. He 
used “technology and the “pratical arts” almost 
interchangeably but distinguished them by associating 
technology with the application of science to the 
pratical, or useful arts. For Bigelow, the sciences 
consisted of discovered principles, ones that exist 
independently of humans. The sciences are 
discovered not invented. We also see technology as a 
creative process involving human ingenuity. The 
word Technology was infrequently used until the late 
twentieth century. When a group of about twenty 
American historians and social scientists formed the 
“Society for the Hystory of technology in 1958, they 
debated whether the society should be known by the 
familiar word “engineering” or the unfamiliar one 
“Technology”. They decided upon the latter, 
believing “technology”, though the less used and less 
well defined term, to be a more inclusive term than 
“engineering”, an activity that it subsumes. So the 
historians of technology today are applying the word 
to word to activities and things in the past not then 
known as technology, but that are similar to activities 
and things in the present that are called technology. 
For example, machines in the nineteenth century and 
mills in the medieval period are called technology 
today, but they were not so designed by 
contemporaries, who called them simply machines 
and mills. Technology, creativity and innovation are 
terms used in the same process describing different 
aspects of the human activities 1.  
The term of innovation derives from the Latin word 
“innovatus”, which is the noun form of “innovare” 
means to renew or change, comes from in-"into" + 
novus-"new". Although the term is broadly used, 
innovation generally refers to the creation of better or 
more effective products, processes, technologies, or 
ideas that are accepted by markets, governments, and 
society. 
During the development of our discipline many men 
and many discoveries have changed the way we see 
cardiovascular diseases and also the way we treat 
them. Innovation and technology have been the 
impetus for the modernization and the profound 
change of our profession. 
 
II. THE WAY WE WERE 
 
Prosthetic Graft 
After the Aortic Transplantation made by Charles 
Dubost in Europe, due to the efforts of Arthur 
Voorhees, Sterling Edwards, and Michael DeBakey, 
prosthetic graft replacement for aortic aneurysms had 
become a reality by the mid-1950s. Many forefathers 
of vascular surgery were involved in the innovative 
and disruptive technology of graft development, but 
Michael DeBakey and his wife’s sewing machine 
were the genesis of the Dacron graft. It is a fascinating 
story, which could not be relived today in our hyper-
regulatory environment. As retold by Dr DeBakey in 
a Journal of Vascular Surgery interview in 1996, he 
was interested in purchasing nylon cloth material to 
make a vascular graft as had been suggested by 
Voorhees. He went to the department store; they were 
out of nylon but did have this new cloth material, 
Dacron. He bought some sheets of Dacron and using 
his wife’s sewing machine created Dacron tubes. A 
couple of years of laboratory work that involved 
replacing the aorta of dogs with the new Dacron graft 
convinced him it was time to move the concept of 
Dacron graft replacement to patients. So he did, and 
the rest is history2. M DeBakey and Stanley Crawford 
pioneered much of aortic surgery, demonstrating that 
large sections of the aorta including those with 
visceral/renal branches could be replaced with 
success. 
There are many other important surgeons in the 
development of aortic surgery, but we have to 
remember Emerick Szilagyi who documented that 
aortic replacement for abdominal aortic aneurysms 
was safe and more effective than nonoperative 
management, well accepted today as a given, although 
the threshold for repair continues to be a subject of 
debate in the era of endovascular aneurysm repair 
(EVAR). Until EVAR, open replacement of the aorta 
by a Dacron graft was the procedure of choice for 
treatment of an abdominal aortic aneurysm. Few 
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thought this would ever change, and it would not have 
without the advent of endovascular therapy. 
In the 1950s, the concept of approaching vascular 
disease through the artery as opposed to outside the 
artery was yet to be born. Vascular disease was 
approached from outside in, with either replacement 
of the diseased vessel or removal of the disease by 
endarterectomy, a technique developed by Dos Santos 
and popularized for carotid and many other surgeons 
world wide, The used technology was represented by 
hands, eyes, motor skills, and surgical judgment in the 
operating room to fix the problem 2. 
 
Endovascular Technology  
Charles Dotter, a radiologist at University of Oregon 
described and performed the first endovascular 
intervention trying to treat vascular disease from 
inside the blood vessel without the large incision and 
minimize patient discomfort and accelerate recovery. 
As he stated in a 1963 address at the Czechoslovakia 
Radiologic Congress, “The angiographic catheter can 
be more than a tool for passive means for diagnostic 
observation, used with imagination it can become an 
important surgical instrument”:  he was clearly way 
ahead of his time, considered by many of his peers and 
all surgeons as “Crazy Charlie”.  
He detailed the procedure of transluminal angioplasty 
in a 1964 publication in Circulation, a paper that 
should be in every vascular surgeon’s library. His 
paper described “transluminal angioplasty” of arterial 
stenoses and occlusions using graduated Teflon 
dilators that were passed endoluminally under 
fluoroscopic guidance. The concept of “Dottering” 
the lesion was born and with the later balloon 
angioplasty angioplasty by Dr Andreas Gruentzig and 
the metal endoluminal stent by Dr Julio Palmaz, 
effective catheter-based therapies were established. 
But our reticence to adopt catheter-based therapies 
was significant 2. 
 
 
By Aortic Endovascular Repair to Endovascular 
Era  
In the year 2000, cardiologist and radiologist realized 
much earlier the role of endovascular procedures in 
the treatment of cardiovascular diseases. We were 
destined to live the legacy of our colleagues in cardiac 
surgery, and it is quite possible vascular surgery 
would have missed the endovascular train leaving the 
station if it was not for Juan Parodi 1.  
He presented his initial experience at a SVS national 
vascular meeting in the early 1990s. A case in point 
was his seminal article, which described his unique 
innovation. The manuscript was initially rejected for 
publication by a major vascular journal with an 
editorial comment to Dr Parodi that it was a crazy idea 
8, but finally, the article was published in the Annals 
of Vascular Surgery. Fast forward to today, reflect for 
a moment on the consequence of his innovation.  
It has resulted in all the benefits first advanced by 
Dotter but not imagined by Dotter for patients with 
aortic disease. Furthermore, it was Parodi’s 
innovation more than any other collegues that made it 
impossible for the house of vascular surgery.  
But application of Parodi’s intervention require 
technology for performing and interpreting imaging 
of the vascular system, and so our konwledge changed 
creating competency and requirement of every 
vascular surgeon in practice today. 
After early years of EVAR practics, Aortic Complex 
procedures are now possible using the sophisticated 
Computed Tomography (CT) and Magnetic 
Resonance (MR) imaging available in current 
practice. These technologies developed in the 1980s 
have permitted the successful application and 
expansion of Parodi’s idea. Without body imaging 
technology, successful endovascular therapy of the 
aorta is less feasible or may be not feasible at all. 
Palpation of pulses, auscultation with a stethoscope, 
and static angiographic images were thought to be all 
that was required to treat a vascular patient. 
The development of “noninvasive imaging” 
technology was fundamental to defining our specialty 
developing in to the endovascular treatment of 
peripheral arterial disease. In the 1970s Eugene 
Strandness, for many of Vascular Surgeons the 
putative “Father of Noninvasive Vascular 
Diagnostics” Professor of Surgery at the University of 
Washington with a team of engineers published in 
1974 the first paper describing the synthesis of B-
mode imaging with Doppler flow detection 3.  
Inherent in this innovation was the concept of vascular 
imaging combined with the objective physiologic 
measurement of blood flow.  
Through this technology, we have been able to 
monitor and correct vascular disease before the 
clinical event and it has revolutionized our approach 
as surgeons to the longitudinal follow-up of our 
patients, which is a unique element of our specialty. 
 
III. THE TECHNOLOGY WILL CHANGE THE 
PROFESSION OF VASCULAR SURGEONS 
 
Veith in 2016 described well the scenario of Vascular 
Surgery after the entry of technology into our 
profession “Following the use of these technologies, 
already 90% of the aortic pathology, 70% of the PAD 
and 40-50% of carotid stenoses can be treated with 
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endovascular techniques”. Among the different fields 
of action of the vascular surgeon I believe that the 
treatment of Thoracic Abdominal Aneurysms and 
shortly after the aortic arch represent this change well, 
showing all of us how technology makes us make 
epochal changes 25. 
Thoraco-abdominal aortic aneurysms (TAAAs) 
considered challenging clinical scenarios are today 
the field of a big change of skills used by surgeons. 
Despite modern intra/peri-operative adjuncts, TAAA 
open repair (OR) has not negligible mortality and 
morbidity rates also in high volume centres. Coselli et 
al 4 reported the largest experience of TAAAs treated 
by OR (3309 cases) with 8% of operative death, 5% 
of spinal cord ischemia and 6% of post-operative 
dialysis. Post-operative cardiac and pulmonary 
complications were 26% and 36%, respectively1. 
Results may be worse in centers with lower case 
volume / experience.  
Fenestrated and branched endografts (FB-EVAR) are 
nowadays available therapeutic options to treat aortic 
aneurysms involving renal and splanchnic arteries.  
Several experiences reported the FB-EVAR 
feasibility and effectiveness for juxta/para-renal 
abdominal aortic aneurysms 5-7.  
For the first time, in 2001 Chuter et al 8 reported the 
total endovascular repair of TAAA by branched 
endograft. In 2010, Bakoyiannis et al 6 reported the 
first literature review of the TAAAs endovascular 
repair by FB-EVAR. Only 7 studies (with early 
results) were collected for an overall of 155 cases.  
Technical success was 94%, 30-day was 7.1% and 
spinal cord ischemia was 9.6% (paraparesis 7.1%, 
paraplegia 2.5%)6.  Re-interventions occurred in 17% 
9. 
In the last years, thanks to the technology evolution 
and the increased operators’ experiences, several 
papers were reported with encouraging early and mid-
term results. Table 1 and 2 summarize peri-operative 
and follow-up results of papers published in the last 
years with more than 150 cases 10-14. 
 
 
Table 1. Literature experiences (>150 cases) reported in 
the last years by high volume centres for FB-EVAR 
repair. Peri-operative results 
 
 
Table 2. Literature experiences (>150 cases) reported in 
the last years by high volume centres for FB-EVAR 




Between January 2010 and July 2017, an overall of 80 
TAAAs (urgent and elective cases) were treated in our 
centre by FB-EVAR. The mean age was 72.5 - SD 7.0 
years and the mean TAAAs diameter was 63.0 - SD 
18.3mm. As regards Crawford’s Classification 1.3% 
were type 1, 23.8% type 2, 27.5% type 3 and 47.4% 
type 4. Five cases were Ruptured TAAAs (6.3%). 
Custom made and off the shelf device were used in 57 
(71.2%) and 23 (28.8%) cases for an overall of 289 
target visceral vessels (3.6 / patient). Technical 
Success was 92.5%. Technical Failures consisted in 1 
Iliac Rupture (1.3%) and 5 Renal Arteries Loss 
(6.2%). The post-operative target visceral vessels 
patency rate was 97.0%. Spinal cord ischemia was 
6%. Cardiac and Pulmonary Complications rates were 
6.3% and 7.5%, respectively. A significant post-
operative renal function worsening (>30% of 
baseline) occurred in 13.8% with a new onset of 
dialysis of 1.3%. The 30-day mortality was 3.8%. The 
mean follow-up was 18.5- SD 15.0 months. The 
overall survival was 96%, 83%, and 70% at 6, 12 and 
24 months.  The overall target visceral vessels (TVV)-
patency was 95%, 93%, and 93% at 6, 12 and 24 
months, respectively. The overall freedom from re-
interventions (FFR) was 87%, 86% and 86% at 6, 12 
and 24 months, respectively. These results are 
comparable with the current literature data published 
by high volume centers for FB-EVAR TAAAs 




In our opinion the advantages of new technologies, 
that have allowed to improve results of FB-EVAR for 
TAAAs in the last years, can be summarized in the 
following points: Pre-operative Planning tools, 
Hybrid Rooms & vessels navigator, Staged 
procedure, Off the shelf endograft, Learning Curve/ 
Dedicated team/ High Volume. 
Preoperative planning is a crucial moment of a 
successful FB-EVAR procedure. Case planning for 
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FB-EVAR requires expertise in computed 
tomography angiography analysis and the ability to 
design a multi-modular endograft with fenestrations 
or branches according to the aorto-iliac anatomy. It is 
time consuming and requires experienced team and 
instruments. Dedicated software are nowadays 
available in order to perform an accurate aorto-iliac 
and visceral vessels anatomical evaluation. By 
computed tomography post processing software, we 
can create volume rendering, multi planar and centre 
lumen line reconstructions or angiographic 
simulation. According with these reconstructions, 
particular evaluations con be performed in order to 
plan a custom made endograft, the endovascular 
strategy and to optimize the entire procedure (patient 
position, access and amount of contrast media).   
Hybrid rooms, combining open surgical environment 
and advanced imaging capabilities are currently 
replacing mobile C-arms in the operating room 15. The 
latest hybrid rooms have advanced imaging 
applications, such as contrast-enhanced cone beam 
computed tomography and preoperative computed 
tomography angiography (CTA) image fusion 15. The 
latter facilitates endovascular navigation (vessel 
navigator – a sort of 3D road map) and increases the 
accuracy of endograft implantation and the target 
visceral vessels cannulation 12. Literature data 
demonstrated that hybrid room and vessels navigator 
significantly reduce the exposure to radiation (for 
both patients and physicians) and the total amount of 
iodinated contrast injection during FB-EVAR12. 
Spinal cord ischemia remains a catastrophic 
complication after the TAAA repair. After OR, the 
rate of SCI ranges between 4 and 11% 4,16,17 and it is 
related with the extension of the aortic disease (TAAA 
type II > I > III e > IV) 4,16-17. After the endovascular 
repair of TAAA, the SCI ranges between 3 and 17% 
12 if we considered the first experiences.  
Recently, different endovascular/surgical strategies 
were proposed to reduce the rate of SCI. Kasprzak et 
al 19 reported a reduction at 5% of SCI by using the 
temporary sac perfusion branches. Maurel et al 4 
associated the concept of the temporary sac perfusion 
with the early lower limb/pelvic perfusion (removing 
as soon as possible the large sheets from the femoral 
arteries). According to this protocol, the SCI rate was 
< al 3%.  Both these approaches are based on the pre-
conditioned theory of the spinal vascular blood supply 
20-21. We always used this approach when it was 
possible; we always maintained the patency of both 
hypogastric/subclavian arteries, and we reported an 
overall rate of spinal cord ischemia of 6% 
(considering both elective and urgent cases). It is 
important to underline also that it is crucial the role of 
the anesthesiological team during the procedure and 
in the peri-operative period to reduce the risk of SCI 
(haemodynamic stability and spinal cord pressure).  
Customization of an appropriate commercially 
available FB-EVAR design requires usually 6-8 
weeks and limits a wide application of this technology 
in urgent patients, such as cases with large 
asymptomatic and symptomatic/ruptured TAAAs. In 
order to expand the availability of FB-EVAR 
technology to acute setting, “off-the-shelf” solutions 
have been proposed to accommodate as many 
different anatomical configurations as possible 22-23. 
Based on this platform, the first off-the-shelf 4-
branched endograft, the Zenith T-Branch endograft 
(Cook Medical, Bloomington, IN, USA), was 
employed and commercially available, starting in 
September 2012 to treat acute TAAA. Preliminary 
experiences suggested that T-branch is a safe and 
effective therapeutics option for urgent total 
endovascular TAAA repair, in which a custom-made 
endograft is not obtainable in the due time 22,23. 
Recently, we reported our experience on urgent 
TAAA endovascular repair by T-branch with 
encouraging results at early and midterm follow-up 23.  
In conclusion, the total endovascular TAAA repair is 
technical demanding, time-consuming, and requires 
dedicated and advanced knowledge in the 
endovascular materials, technologies and dedicated 
team for planning, procedure and peri-operative 
management. The expertise is a key factor to treat 
challenging FB-EVAR cases. In 2016 Starnes 
published an experience about the importance of the 
learning curve in these advanced procedures 24. 
During the course of 136 consecutive single-surgeon 
FEVAR implantations, the authors have demonstrated 
statistically significant and clinically meaningful 
improvements in several outcomes during the study 
period, including perioperative death or major 
complications, length of procedure, and fluoroscopy 
time 24. (decrease in the proportion of patients 
suffering perioperative death or major complications 
from 23.5% in the first quartile to 8.8% in the fourth 
quartile. After adjustment for potential confounding 
factors, the odds of death or major complication were 




Our discipline after having spent years to affirm its 
identity and autonomy with respect to general surgery, 
is today actually included in the specializations that 
take care of cardio-thoracic vascular diseases, sharing 
diagnostic and therapeutic pathways. The surgical 
instruments used are largely different, and as 
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recommended by Dotter's first experience, catheters, 
guides and metal stents have become the new surgical 
instruments. But the most important aspect concerns 
the overbearing entry into our profession of 
technological innovations that are decisively 
changing our work. The current vascular surgeon is in 
need of expertise in the use of technologies that were 
previously a prerogative of Radiologists and / or 
Cardiologists, CT and MR, 3D Virtual Reality 
simulations are close to entering our daily work. At 
the same time, the open surgical operations performed 
by our young people in training are reduced and for 
some of us insufficient to guarantee the necessary 
capacity for carrying out major interventions. 
It is time to rethink the contents and training paths of 
Vascular Surgery because today our young surgeons 
are not always able to find the contents necessary to 
create the required skills in the field of radiology and 
cardiology within the current training paths. In the 
future, we will have to design a new territorial 
distribution of the Vascular Surgery Units with 
different surgical skills as required by the current 
specialist, technological and economic needs.  
What about the future for vascular surgery in 10 years 
and beyond? What changes should we expect? First, 
we can share what was reported by F Veith, which 
with the development of technology and the increased 
capabilities of vascular surgeons, “By 2026, one can 
predict that 75% to 95% of all vascular lesions 
requiring treatment will undergo an endovascular 
procedure” 25. 
How should vascular surgery deal with the decreasing 
numbers of complex open procedures and who should 
do them? One solution is to have centers to which 
these patients are sent and in which vascular surgeons 
seeking this skill can get adequate open training.  
Nevertheless, Vascular surgery has progressed over 
time thanks to the development of other sciences such 
as pharmacology for heparin, engineering for 
imaging, we can therefore predict that the definition 
of the best medical therapies together with the genetic 
therapies will allow us to reduce the development of 
diseases such as atherosclerosis. 
Statin drugs are just the beginning and have already 
decreased rates of heart attacks, strokes, and death. 
Better use of these drugs will make them more 
effective, improve our treatments, and help our 
patients have longer and better lives. Despite this and 
the possibility of even more effective lipid-lowering 
therapy, complications of atherosclerosis will still 
occur and require our interventions, probably in 
increasing numbers as our population ages. This 
ensures a continuing need for the services vascular 
surgeons provide 25. 
Vascular surgery has evolved more and is now further 
differentiated, from its general surgery ancestor, we 
have become more endovascular, while general 
surgery has become more laparoscopic. So vascular 
surgery is even more qualified now for separate 
specialty status than it was in 2007 after Europe and 
more recently also in USA. on the world 25-26. 
Similarly, the already promising results of AAA, 
Abdominal aortic aneurysm. drug-coated balloons 
will be enhanced. All these devices are complicated 
with many variable factors. The bottom line is that 
intimal hyperplasia will be overcome by anti-
proliferative drugs in all vascular beds once the best 
way of getting the best drug to the proper location is 
found. And finally, computer-enabled remote 
monitoring of flows within grafts and stents will allow 
corrective treatment before occlusion occurs. 
Miniaturized piezoelectric sensors are one way to do 
this. 
Finally, we live in an imperfect world and yes, we see 
it in our health care system, in which doctors are able 
to perform unnecessary procedures for financial gain: 
the overtreratment is ever possible, sometime 
influencing the published data. 
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